Longitudinal T-LGLL characteristics of patients with leukemia
. | STAT3MT . | Hematologic presentation . | AAD, y . | Sex . | Therapy . | LGL count* . | Flow cytometry . | TCR deep sequencing . | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
VB ID . | Clone size*, % . | Major clonotype(s) . | Clone size*, % . | Clonal diversity*,† . | Clonality*,† . | |||||||
CCF1 | D661V | Anemia | 68 | M | CSA, CYC, MTX | 2455 | NIP | 65 | CASSLLAGGYNEQFF | 42 | 0.176 | 0.373 |
CCF2 | D661V | Neutropenia thrombocytopenia | 81 | M | MTX | 1225 | TRBV9 | 72 | CASSVGQGSPLHF | 75 | 0.565 | 0.734 |
CCF3 | Y640F | Neutropenia thrombocytopenia | 55 | F | CSA | 1355 | TRBV6-2, TRBV3-1 | 25, 16 | CASSLASISYNEQFF | 26 | 0.068 | 0.263 |
CCF4 | D661Y, Y640F | Pancytopenia | 64 | M | CSA, MTX | 3672 | TRBV10-3 | 23 | CASSAPREGTAYEQYF, CASSPTSGGEQFF | 8, 5 | 0.016 | 0.222 |
CCF5 | D661Y | Anemia, neutropenia | 54 | M | CSA, CYC | 10 631 | TRBV9 | 99 | CASSVGRFQETQYF | 44 | 0.192 | 0.378 |
CCF6 | Y640F | Neutropenia | 47 | M | CSA, CYC, MTX | 850 | TRBV29-1 | 8, 11 | CASSTFAEIRQPQHF, CASSLTENYGYTF | 4, 0.01 | 0.002 | 0.046 |
CCF7 | D661Y | Neutropenia | 40 | M | CSA, CYC, MTX | 2882 | NIP | 95 | CATSRGTGDSYEQYF | 97 | 0.934 | 0.938 |
CCF8 | Y640F | Anemia, neutropenia | 37 | F | CSA | 480 | TRBV12-3, TRBV12-4 | 82 | CASSSLTGLPPYEQYF | 29 | 0.085 | 0.247 |
CCF9 | Y640F | Anemia, neutropenia | 74 | F | CSA, CYC, MTX | 496 | NIP | 96 | CASSPEGFQPQHF, CASTSFGTGTDTQYF | 91, 0.16 | 0.819 | 0.871 |
CCF10 | Negative | Anemia, neutropenia | 17 | M | CSA, MTX | 330 | TRBV18 | 77 | CASSPFWTLEKLFF | 93 | 0.871 | 0.893 |
CCF11 | Negative | Anemia | 63 | M | CSA, CYC, MTX | 980 | TRVB28, TRBV19 | 32, 18 | CASSPLGAVGYNEQFF, CAISEFPGGQTSDEGFF | 25, 1 | 0.086 | 0.471 |
CCF12 | Negative | Neutropenia | 47 | F | CSA, MTX | 188 | TRBV12-3, TRBV12-4 | 45 | CASSIAGLGSEQFF, CASSEGQMYNEQFF | 12, 3 | 0.019 | 0.191 |
CCF13 | Negative | Anemia, neutropenia | 52 | F | CSA, CYC, MTX | 261 | TRBV13 | 97 | CASSDLAGMLGRQFF | 99 | 0.983 | 0.984 |
CCF14 | Negative | Anemia | 66 | M | CYC | 409 | NIP, TRBV20-1 | 84, 24 | CASSLEIAGGLIYNEQFF, CASSPGLAGGRETQYF | 27, 2 | 0.093 | 0.350 |
CCF15 | Negative | Anemia, neutropenia | 60 | M | CSA, CYC, MDX | 4472 | TRBV19 | 97 | CASSIGIQPQHF | 83 | 0.686 | 0.791 |
CCF16 | Negative | Asymptomatic | 59 | M | SCT, CYC | 1515 | TRBV27 | 30 | CASSSVGYEQYF | 40 | 0.173 | 0.478 |
CCF17 | Negative | Anemia | 71 | F | MTX | 2536 | TRBV19 | 20 | CASRASGSDEQYF, CARSRDKGTDYGYTF | 10, 8 | 0.024 | 0.263 |
CCF18 | Negative | Asymptomatic | 54 | M | None | 686 | TRBV27, TRVB4-3 | 12, 8 | CASSLGNYEQYF, CASSISQNTEAFF | 4, 7 | 0.026 | 0.319 |
. | STAT3MT . | Hematologic presentation . | AAD, y . | Sex . | Therapy . | LGL count* . | Flow cytometry . | TCR deep sequencing . | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
VB ID . | Clone size*, % . | Major clonotype(s) . | Clone size*, % . | Clonal diversity*,† . | Clonality*,† . | |||||||
CCF1 | D661V | Anemia | 68 | M | CSA, CYC, MTX | 2455 | NIP | 65 | CASSLLAGGYNEQFF | 42 | 0.176 | 0.373 |
CCF2 | D661V | Neutropenia thrombocytopenia | 81 | M | MTX | 1225 | TRBV9 | 72 | CASSVGQGSPLHF | 75 | 0.565 | 0.734 |
CCF3 | Y640F | Neutropenia thrombocytopenia | 55 | F | CSA | 1355 | TRBV6-2, TRBV3-1 | 25, 16 | CASSLASISYNEQFF | 26 | 0.068 | 0.263 |
CCF4 | D661Y, Y640F | Pancytopenia | 64 | M | CSA, MTX | 3672 | TRBV10-3 | 23 | CASSAPREGTAYEQYF, CASSPTSGGEQFF | 8, 5 | 0.016 | 0.222 |
CCF5 | D661Y | Anemia, neutropenia | 54 | M | CSA, CYC | 10 631 | TRBV9 | 99 | CASSVGRFQETQYF | 44 | 0.192 | 0.378 |
CCF6 | Y640F | Neutropenia | 47 | M | CSA, CYC, MTX | 850 | TRBV29-1 | 8, 11 | CASSTFAEIRQPQHF, CASSLTENYGYTF | 4, 0.01 | 0.002 | 0.046 |
CCF7 | D661Y | Neutropenia | 40 | M | CSA, CYC, MTX | 2882 | NIP | 95 | CATSRGTGDSYEQYF | 97 | 0.934 | 0.938 |
CCF8 | Y640F | Anemia, neutropenia | 37 | F | CSA | 480 | TRBV12-3, TRBV12-4 | 82 | CASSSLTGLPPYEQYF | 29 | 0.085 | 0.247 |
CCF9 | Y640F | Anemia, neutropenia | 74 | F | CSA, CYC, MTX | 496 | NIP | 96 | CASSPEGFQPQHF, CASTSFGTGTDTQYF | 91, 0.16 | 0.819 | 0.871 |
CCF10 | Negative | Anemia, neutropenia | 17 | M | CSA, MTX | 330 | TRBV18 | 77 | CASSPFWTLEKLFF | 93 | 0.871 | 0.893 |
CCF11 | Negative | Anemia | 63 | M | CSA, CYC, MTX | 980 | TRVB28, TRBV19 | 32, 18 | CASSPLGAVGYNEQFF, CAISEFPGGQTSDEGFF | 25, 1 | 0.086 | 0.471 |
CCF12 | Negative | Neutropenia | 47 | F | CSA, MTX | 188 | TRBV12-3, TRBV12-4 | 45 | CASSIAGLGSEQFF, CASSEGQMYNEQFF | 12, 3 | 0.019 | 0.191 |
CCF13 | Negative | Anemia, neutropenia | 52 | F | CSA, CYC, MTX | 261 | TRBV13 | 97 | CASSDLAGMLGRQFF | 99 | 0.983 | 0.984 |
CCF14 | Negative | Anemia | 66 | M | CYC | 409 | NIP, TRBV20-1 | 84, 24 | CASSLEIAGGLIYNEQFF, CASSPGLAGGRETQYF | 27, 2 | 0.093 | 0.350 |
CCF15 | Negative | Anemia, neutropenia | 60 | M | CSA, CYC, MDX | 4472 | TRBV19 | 97 | CASSIGIQPQHF | 83 | 0.686 | 0.791 |
CCF16 | Negative | Asymptomatic | 59 | M | SCT, CYC | 1515 | TRBV27 | 30 | CASSSVGYEQYF | 40 | 0.173 | 0.478 |
CCF17 | Negative | Anemia | 71 | F | MTX | 2536 | TRBV19 | 20 | CASRASGSDEQYF, CARSRDKGTDYGYTF | 10, 8 | 0.024 | 0.263 |
CCF18 | Negative | Asymptomatic | 54 | M | None | 686 | TRBV27, TRVB4-3 | 12, 8 | CASSLGNYEQYF, CASSISQNTEAFF | 4, 7 | 0.026 | 0.319 |
AAD, age at diagnosis; CSA, cyclosporine-A; CYC, cyclophosphamide; F, female; FU, follow-up; M, male; MTX, methotrexate; SCT, stem cell transplant.
*At earliest sampling.
†Clonal diversity and Clonality assessed according to Clemente et al.9